Another potential explanation for the observed variability in C‐peptide levels over time is the differences in insulin sensitivity progression over time among individuals with T2D, as C‐peptide reflects both beta cell function and insulin sensitivity. This evidence concerns the gene INS and type 2 diabetes mellitus.